ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant

ASTRO-LUNGevity Radiation Oncology Seed Grant

Funds the ASTRO-LUNGevity Radiation Oncology Seed Grant for trainees in radiation oncology to launch lung cancer studies.

⚠ This may reflect a past cycle — verify the current call on the funder's site.

The ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant is a one-year award of $50,000 offered jointly by LUNGevity Foundation and ASTRO (American Society for Radiation Oncology) to support radiation oncology trainees in conducting lung cancer research. The award is designed to provide residents and fellows in accredited radiation oncology training programmes with the financial foundation to initiate independent research before completing their clinical training. Eligible research spans basic, translational, and clinical investigations with relevance to lung cancer, including radiobiology, treatment planning, and outcomes research.

Applicants must be current residents or fellows enrolled in a radiation oncology programme at an academic or research institution; faculty-level investigators are not eligible. No explicit country restriction is listed in programme materials, though the institutional affiliation with an accredited radiation oncology training programme is a practical requirement. Applications for the 2026 cycle were submitted through Proposal Central, with a deadline of January 26, 2026, placing the 2026 cycle's application phase already closed. The seed grant mechanism is intended to generate preliminary data that positions trainees for larger career-development or investigator-initiated awards after training completion.

Strong applications present a focused scientific question addressable within a one-year timeline and demonstrate that the trainee has protected research time, an identified faculty mentor, and access to relevant patient populations or laboratory resources. The joint ASTRO-LUNGevity structure means that applications are evaluated for both scientific merit and fit with radiation oncology's specific contribution to lung cancer management. Trainees interested in future cycles should monitor both LUNGevity's and ASTRO's grant announcement pages for the next call, which historically opens in the autumn preceding the January deadline.